1 Nov 2018 Censa Pharmaceuticals completes Phase I study and initiates enrollment into Phase II studies
28 Jul 2018 Censa appoints new VP of Regulatory Affairs, Associate VP of Clinical Operations and Director of Quality
5 Jan 2018 Retrophin and Censa Pharmaceuticals Enter into Strategic Collaboration to Advance CNSA-001 for the Treatment of Phenylketonuria (PKU)
